Literature DB >> 15297676

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.

Salim I Khakoo1, Chloe L Thio, Maureen P Martin, Collin R Brooks, Xiaojiang Gao, Jacquie Astemborski, Jie Cheng, James J Goedert, David Vlahov, Margaret Hilgartner, Steven Cox, Ann-Margeret Little, Graeme J Alexander, Matthew E Cramp, Stephen J O'Brien, William M C Rosenberg, David L Thomas, Mary Carrington.   

Abstract

Natural killer (NK) cells provide a central defense against viral infection by using inhibitory and activation receptors for major histocompatibility complex class I molecules as a means of controlling their activity. We show that genes encoding the inhibitory NK cell receptor KIR2DL3 and its human leukocyte antigen C group 1 (HLA-C1) ligand directly influence resolution of hepatitis C virus (HCV) infection. This effect was observed in Caucasians and African Americans with expected low infectious doses of HCV but not in those with high-dose exposure, in whom the innate immune response is likely overwhelmed. The data strongly suggest that inhibitory NK cell interactions are important in determining antiviral immunity and that diminished inhibitory responses confer protection against HCV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15297676     DOI: 10.1126/science.1097670

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  469 in total

Review 1.  Induction and evasion of innate antiviral responses by hepatitis C virus.

Authors:  Stanley M Lemon
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Analytical methods for disease association studies with immunogenetic data.

Authors:  Jill A Hollenbach; Steven J Mack; Glenys Thomson; Pierre-Antoine Gourraud
Journal:  Methods Mol Biol       Date:  2012

3.  Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity.

Authors:  Philipp A Lang; Karl S Lang; Haifeng C Xu; Melanie Grusdat; Ian A Parish; Mike Recher; Alisha R Elford; Salim Dhanji; Namir Shaabani; Charles W Tran; Dilan Dissanayake; Ramtin Rahbar; Magar Ghazarian; Anne Brüstle; Jason Fine; Peter Chen; Casey T Weaver; Christoph Klose; Andreas Diefenbach; Dieter Häussinger; James R Carlyle; Susan M Kaech; Tak W Mak; Pamela S Ohashi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-13       Impact factor: 11.205

4.  Genetic polymorphism in IL28B is associated with spontaneous clearance of hepatitis C virus genotype 4 infection in an Egyptian cohort.

Authors:  Fuat Kurbanov; Mohamed Abdel-Hamid; Rachel Latanich; Jacquie Astemborski; Mostafa Mohamed; Nabiel Mh Mikhail; Mai El-Daly; Sherif El-Kafrawy; David L Thomas; Chloe L Thio
Journal:  J Infect Dis       Date:  2011-09-20       Impact factor: 5.226

5.  Understanding the natural history of chronic HBV and HCV infections.

Authors:  David L Thomas; Adrian M Di Bisceglie; Harvey J Alter; Norah A Terrault
Journal:  J Fam Pract       Date:  2010-04       Impact factor: 0.493

6.  Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.

Authors:  Mark H Kuniholm; Andrea Kovacs; Xiaojiang Gao; Xiaonan Xue; Darlene Marti; Chloe L Thio; Marion G Peters; Norah A Terrault; Ruth M Greenblatt; James J Goedert; Mardge H Cohen; Howard Minkoff; Stephen J Gange; Kathryn Anastos; Melissa Fazzari; Tiffany G Harris; Mary A Young; Howard D Strickler; Mary Carrington
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

7.  Therapeutic depletion of natural killer cells controls persistent infection.

Authors:  Stephen N Waggoner; Keith A Daniels; Raymond M Welsh
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

Review 8.  Hepatitis C virus in pregnancy.

Authors:  Mona R Prasad; Jonathan R Honegger
Journal:  Am J Perinatol       Date:  2013-02-06       Impact factor: 1.862

9.  Role of genetic polymorphisms in hepatitis C virus chronic infection.

Authors:  Nicola Coppola; Mariantonietta Pisaturo; Caterina Sagnelli; Lorenzo Onorato; Evangelista Sagnelli
Journal:  World J Clin Cases       Date:  2015-09-16       Impact factor: 1.337

10.  Hepatitis C Virus (HCV) NS3 sequence diversity and antiviral resistance-associated variant frequency in HCV/HIV coinfection.

Authors:  Cassandra B Jabara; Fengyu Hu; Katie R Mollan; Sara E Williford; Prema Menezes; Yan Yang; Joseph J Eron; Michael W Fried; Michael G Hudgens; Corbin D Jones; Ronald Swanstrom; Stanley M Lemon
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.